Related Experiment Video
Updated: Jul 21, 2026

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
Biomarker screening for pulmonary hypertension in VLBW infants at risk for bronchopulmonary dysplasia
Fernando A Munoz1, Amanda Kim2, Brendan Kelly3
1Division of Neonatology, Department of Pediatrics, Oregon Health & Science University, Portland, OR, USA. munozf@ohsu.edu.
Insights
Biomarkers NT-proBNP and bicarbonate can help identify very low birth weight (VLBW) infants at low risk for bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH). This combination may help avoid unnecessary echocardiograms for VLBW infants.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Respiratory Medicine
Background:
- Very low birth weight (VLBW) infants have abnormal lung development, increasing their risk for bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH).
- Accurate risk stratification for BPD-associated PH (BPD-PH) is crucial for timely management and improved outcomes in these vulnerable infants.
Purpose of the Study:
- To evaluate the effectiveness of NT-proBNP and bicarbonate levels in identifying VLBW infants at low risk for BPD-PH.
- To determine if a combined biomarker approach can reduce the need for screening echocardiograms in VLBW infants.
Main Methods:
- VLBW infants on respiratory support at 34 weeks corrected gestational age were screened using blood gas, serum NT-proBNP, and bicarbonate (HCO3) levels.
- Eleven predictive models were tested using various cutoffs for NT-proBNP and HCO3 to identify infants at low risk for BPD-PH.
Main Results:
- Pulmonary hypertension (PH) was detected in 17.6% of VLBW infants.
- A model combining NT-proBNP < 950 pg/mL and HCO3 < 32 mmol/L demonstrated 100% sensitivity and 100% negative predictive value for BPD-PH.
- This model could have identified 28% of infants as low risk, potentially avoiding echocardiography.
Conclusions:
- Serum NT-proBNP and bicarbonate levels are sensitive and cost-effective screening tools for BPD-PH in VLBW infants.
- The combination of NT-proBNP and HCO3 is more effective than NT-proBNP alone in identifying VLBW infants who may avoid screening echocardiography.
Background:
Very low birth weight (VLBW) infants demonstrate altered alveolar and pulmonary vascular development and carry an increased risk of developing bronchopulmonary dysplasia (BPD) and pulmonary hypertension (PH). Risk stratification for BPD-associated PH (BPD-PH) in at-risk infants may help tailor management, improve outcomes, and optimize resource utilization.
Methods:
VLBW infants were screened for PH with blood gas measurements, serum NT-proBNP and bicarbonate (HCO3) levels, and echocardiograms if they remained on respiratory support at 34 weeks corrected gestational age. We then tested 11 models using different cutoffs for NT-proBNP and HCO3 to predict infants at low risk of BPD-PH.
Results:
We identified PH in 34 of 192 (17.6%) VLBW infants. The median NT-proBNP in VLBWs with PH was 2769 pg/mL versus 917 pg/mL in those without PH (p < 0.0001). A model with NT-proBNP < 950 pg/mL and HCO3 < 32 mmol/L had a sensitivity of 100%, specificity of 34.2%, and negative predictive value of 100%. Using this model, 54 of 192 (28%) of the patients in this study would have been categorized as low risk for PH and could have avoided a screening echocardiogram.
Conclusion:
NT-proBNP and HCO3 together may serve as sensitive and cost-effective screening tools for BPD-PH in VLBW infants.
Impact:
NT-proBNP and HCO3 concentrations obtained together may help identify very low birth weight infants at risk for bronchopulmonary dysplasia who should undergo screening for pulmonary hypertension with echocardiography. This large dataset demonstrates that NT-proBNP and HCO3 levels together are more sensitive than NT-proBNP alone in identifying VLBW infants to undergo echocardiography. The combination of NT-proBNP and HCO3 levels may identify VLBW infants at low risk for pulmonary hypertension and thus those who may be able to avoid screening echocardiography.
More Related Videos
08:08Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Related Concept Videos
Assessment of Ventilation I: Respiratory Rate
A Ventilation assessment is critical for monitoring a patient's health status. Respiration, one of the most accessible vital signs, provides insights into the function of numerous body systems and can indicate serious health issues, such as brainstem injuries from head trauma.
Critical Guidelines for Assessing Ventilation:
Measurement of Blood Pressure
Blood Studies I: ABG and VBG
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to reabsorb or...
Mitral Valve Prolapse III: Nursing Management